Global Advocacy: Progress Report
Melanoma is a global disease. In the United States, one person dies every 54 minutes from melanoma. Australia and New…
11/13/2018
Global Advocacy: Progress Report
Melanoma is a global disease. In the United States, one person dies every 54 minutes from melanoma. Australia and New…
|
11/13/2018
The Melanoma Tissue Bank: Progress Report
As we look back through 2018, perhaps the most exciting news from AIM at Melanoma is the progress on what…
|
|
10/08/2018
Consejos de compra para cuidadores de pacientes con melanoma
Shop with a list: Make copies of a standard a grocery list that can be added to each week which includes…
|
09/05/2018
En lenguaje sencillo: El ensayo clínico Keynote 716
En el momento de escribir este artículo, hay 477 ensayos clínicos sobre melanoma en ClinicalTrial.gov que están reclutando pacientes activamente, y otros 65...
|
09/04/2018
Preguntas y respuestas de tres destacados especialistas en melanoma
Eric D. Whitman, MD Medical Director, Atlantic Health System Cancer Care Director, Atlantic Melanoma Center Question: Which clinical trials do…
|
08/30/2018
El melanoma por estados: Vermont
Vermont es un estado conocido por sus bosques nacionales y estatales, sus majestuosas montañas nevadas, su delicioso sirope de arce y Ben and Jerry's...
|
07/31/2018
AIM Announces New Partnership With The Society for Immunotherapy of Cancer (SITC)
AIM at Melanoma is proud to announce our new online educational partnership with the Society for Immunotherapy of Cancer…
|
07/03/2018
El melanoma por estados: Minnesota
Minnesota tops Midwest in melanoma incidences Minnesota has the third highest incidence rate of melanoma in the United States, tied with New…
|
06/27/2018
Para Tracy Welge, la cura está en la bolsa
Conozca a Tracy Welge, una mujer de 41 años, madre y superviviente de un melanoma en Naperville, Illinois. Dos diagnósticos de melanoma, un espíritu emprendedor y una...
|
|
04/27/2018
Q&A with Omid Hamid, MD, Director of the Melanoma Center and Phase I Immuno-Oncology Program at The Angeles Clinic and Research Institute
Dr. Omid Hamid is recognized nationally and internationally as a key opinion leader in Immuno-Oncologic Drug Development and Melanoma…
|
Entradas recientes
Apr. 16, 2024
Navigating the Journey Together – Conversations with Melanoma Caregivers
Apr. 12, 2024
May is Brain Tumor Awareness Month
Apr. 11, 2024
President’s Letter | April 2024
Apr. 11, 2024
Celebrating a Milestone: 20 Years of the Dallas Steps Against Melanoma Walk
Apr. 11, 2024